Trader,
Nice find. Would be nice if someone would actually write an accurate assessment of ZIVO. This one is also off the mark in some comments. Of course the "accurate" assessment of ZIVO isn't the prettiest of pictures.
Guess the guy wanting to dump a million shares doesn't see it that way.
>>>>>>>>>>>>
ZIVO Bioscience (OTCQB:ZIVO)
The smallest company on this list with a market capitalization of $14 million, I included ZIVO due to its interesting, low capital cost business model, and the amount of validation the company has received in regards to its partnerships and collaborations.
The company develops and commercializes nutritional compounds and bioactive molecules generated by its proprietary algal strains. This is to say; that ZIVO is able to mitigate most of the risk involved in the costly development of an in house growing facility and expensive CO2 inputs. The company has a number of potential monetization opportunities in human nutrition, animal feed, and animal therapeutics. I believe the most compelling near term opportunity stems from their animal health collaboration with Zoetis (NYSE:ZTS).This "most compelling near term opportunity" has been collecting dust for well over a year. This is not even close to being a near term opportunity.
Zoetis was spun out of Pfizer, and is the largest producer of medicine and vaccinations for pets and livestock. With a market cap of over $26 billion, the collaboration with Zoetis serves to validate the opportunity in ZIVO's proprietary algal strain. With the partnership intended to target Bovine MastitisThere is no "partnership" between the two outside of collaborating on some testing for bovine mastitis., a disease that costs the U.S. Dairy Industry over $2 billion annually or 11% of total milk production. Success on this therapeutic would represent a substantial royalty for ZIVO. Moreover, due to the increased regulation on use of antibiotics on livestock, the bovine market would readily accept the therapy for mastitis. The company appears to have enough capital to power the pilot production and validation studies required to continue with the collaboration.LOL .... it does ? From where ?
What I also found interesting about the company is its association with Synthetic Genomics. Synthetics Genomics (founded by Craig Venter, man who mapped the human genome) was the private company that received $500 million from ExxonMobil to produce an economically viable biodiesel. If ZIVO's proprietary algae strains exhibit a desirable trait to Synthetic Genomics, which may open the door to receiving potential biodiesel funding.What does this even mean. ZIVO ain't doin' biofuels. A waste of time and costs waaaaaayyyyy too much money
<<<<<<<<<<<<<
Someone is certainly tweaking ZIVO mention machine that is for sure. I think I know who that person is but I'll just leave it at that as I've mentioned ZIVO had a new IR previously.
Amigo Mike
AI
